Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
08 May 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217195
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
About the Company : Sentiss is an integrated pharmaceutical company headquartered in India selling products globally. Sentiss develops, manufactures and markets a wide range of sterile ophthalmic, respiratory and o...
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;INHALATION
Brand Name : ALBUTEROL SULFATE
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 1998-01-15
Application Number : 74543
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Dosage Form : SOLUTION/DROPS;OPHTHALMI...
Brand Name : BRIMONIDINE TARTRATE AND ...
Dosage Strength : 0.2%;EQ 0.5% BASE
Packaging :
Approval Date : 2022-10-31
Application Number : 91086
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION/DROPS;OPHTHALMI...
Brand Name : BROMFENAC SODIUM
Dosage Strength : EQ 0.09% ACID
Packaging :
Approval Date : 2014-01-22
Application Number : 203395
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SUSPENSION/DROPS;OTIC
Brand Name : CIPROFLOXACIN AND DEXAMET...
Dosage Strength : 0.3%;0.1%
Packaging :
Approval Date : 2023-06-09
Application Number : 215768
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : OINTMENT;OPHTHALMIC
Brand Name : ERYTHROMYCIN
Dosage Strength : 0.5%
Packaging :
Approval Date : 1996-07-18
Application Number : 64030
Regulatory Info : RX
Registration Country : USA
Regulatory Info : OTC
Registration Country : USA
Dosage Form : SOLUTION/DROPS;OPHTHALMI...
Brand Name : KETOTIFEN FUMARATE
Dosage Strength : EQ 0.025% BASE
Packaging :
Approval Date : 2007-07-26
Application Number : 77958
Regulatory Info : OTC
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : JELLY;TOPICAL
Brand Name : LIDOCAINE HYDROCHLORIDE
Dosage Strength : 2%
Packaging :
Approval Date : 2003-02-12
Application Number : 40433
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SUSPENSION/DROPS;OPHTHAL...
Brand Name : LOTEPREDNOL ETABONATE
Dosage Strength : 0.5%
Packaging :
Approval Date : 2019-04-17
Application Number : 207609
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : GEL;OPHTHALMIC
Brand Name : LOTEPREDNOL ETABONATE
Dosage Strength : 0.5%
Packaging :
Approval Date : 2021-02-10
Application Number : 212080
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : SUSPENSION/DROPS;OPHTHAL...
Brand Name : LOTEPREDNOL ETABONATE
Dosage Strength : 0.2%
Packaging :
Approval Date : 2023-04-12
Application Number : 215933
Regulatory Info : RX
Registration Country : USA
RLD : No
TE Code : AN
Dosage Form : SOLUTION; INHALATION
Proprietary Name : ALBUTEROL SULFATE
Dosage Strength : EQ 0.5% BASE
Approval Date : 1998-01-15
Application Number : 74543
RX/OTC/DISCN : RX
RLD : No
TE Code : AN
RLD : No
TE Code : AB
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : BRIMONIDINE TARTRATE AND...
Dosage Strength : 0.2%;EQ 0.5% BASE
Approval Date : 2022-10-31
Application Number : 91086
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AT2
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : BROMFENAC SODIUM
Dosage Strength : EQ 0.09% ACID
Approval Date : 2014-01-22
Application Number : 203395
RX/OTC/DISCN : RX
RLD : No
TE Code : AT2
RLD : No
TE Code : AB
Dosage Form : SUSPENSION/DROPS; OTIC
Proprietary Name : CIPROFLOXACIN AND DEXAME...
Dosage Strength : 0.3%;0.1%
Approval Date : 2023-06-09
Application Number : 215768
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AT
Dosage Form : OINTMENT; OPHTHALMIC
Proprietary Name : ERYTHROMYCIN
Dosage Strength : 0.5%
Approval Date : 1996-07-18
Application Number : 64030
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code :
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : KETOTIFEN FUMARATE
Dosage Strength : EQ 0.025% BASE
Approval Date : 2007-07-26
Application Number : 77958
RX/OTC/DISCN : OTC
RLD : No
TE Code :
RLD : No
TE Code : AT
Dosage Form : JELLY; TOPICAL
Proprietary Name : LIDOCAINE HYDROCHLORIDE
Dosage Strength : 2%
Approval Date : 2003-02-12
Application Number : 40433
RX/OTC/DISCN : RX
RLD : No
TE Code : AT
RLD : No
TE Code : AB
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Proprietary Name : LOTEPREDNOL ETABONATE
Dosage Strength : 0.5%
Approval Date : 2019-04-17
Application Number : 207609
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : GEL; OPHTHALMIC
Proprietary Name : LOTEPREDNOL ETABONATE
Dosage Strength : 0.5%
Approval Date : 2021-02-10
Application Number : 212080
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : SUSPENSION/DROPS; OPHTHALMIC
Proprietary Name : LOTEPREDNOL ETABONATE
Dosage Strength : 0.2%
Approval Date : 2023-04-12
Application Number : 215933
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Services
Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Injectable / Parenteral
Sub Category : Overview
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Category : Solution
Sub Category : Ophthalmic
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
Pharma Service : Drug Product Manufacturing
API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Ophthalmic
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Emulsion
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Suspension
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Otic
Pharma Service : API & Drug Product Development
Pharma Service : API & Drug Product Development
Category : Formulation Development
Sub Category : Inhalation / Nasal
Pharma Service : API & Drug Product Development
Inspections and registrations
District Decision : Official Action Indicated
Inspection End Date : 2013-04-03
City : District Solan,
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Official Action Indicated
Inspection End Date : 2013-04-03
District Decision : Official Action Indicated
Inspection End Date : 2017-05-23
City : District Solan
State :
Country/Area : IN
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Official Action Indicated
Inspection End Date : 2017-05-23
ABOUT THIS PAGE
Sentiss Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Benzododecinium bromide bulk offered by Sentiss Pharma
LOOKING FOR A SUPPLIER?